Texas Permanent School Fund’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $582K | Buy |
+21,631
| New | +$582K | 0.01% | 1375 |
|
|
2024
Q3 | – | Sell |
-37,032
| Closed | -$1.06M | – | 1006 |
|
|
2024
Q2 | $1.06M | Sell |
37,032
-3,610
| -9% | -$103K | 0.01% | 1277 |
|
|
2024
Q1 | $1.19M | Buy |
40,642
+543
| +1% | +$15.9K | 0.01% | 1267 |
|
|
2023
Q4 | $1.35M | Buy |
40,099
+695
| +2% | +$23.4K | 0.01% | 1212 |
|
|
2023
Q3 | $1.21M | Sell |
39,404
-948
| -2% | -$29.1K | 0.01% | 1172 |
|
|
2023
Q2 | $1.62M | Sell |
40,352
-672
| -2% | -$26.9K | 0.02% | 1083 |
|
|
2023
Q1 | $1.67M | Buy |
41,024
+10,178
| +33% | +$415K | 0.02% | 1042 |
|
|
2022
Q4 | $1.19M | Sell |
30,846
-2,113
| -6% | -$81.6K | 0.02% | 1036 |
|
|
2022
Q3 | $1.75M | Buy |
32,959
+118
| +0.4% | +$6.28K | 0.03% | 824 |
|
|
2022
Q2 | $1.92M | Buy |
32,841
+1,261
| +4% | +$73.5K | 0.03% | 788 |
|
|
2022
Q1 | $2.41M | Sell |
31,580
-535
| -2% | -$40.8K | 0.03% | 733 |
|
|
2021
Q4 | $1.93M | Sell |
32,115
-770
| -2% | -$46.3K | 0.02% | 930 |
|
|
2021
Q3 | $1.84M | Buy |
32,885
+76
| +0.2% | +$4.26K | 0.02% | 940 |
|
|
2021
Q2 | $1.99M | Buy |
32,809
+39
| +0.1% | +$2.37K | 0.02% | 921 |
|
|
2021
Q1 | $2.3M | Sell |
32,770
-2,113
| -6% | -$148K | 0.03% | 820 |
|
|
2020
Q4 | $2.09M | Sell |
34,883
-5,042
| -13% | -$302K | 0.03% | 822 |
|
|
2020
Q3 | $2.4M | Buy |
39,925
+6,646
| +20% | +$400K | 0.03% | 668 |
|
|
2020
Q2 | $1.75M | Sell |
33,279
-2,217
| -6% | -$116K | 0.03% | 765 |
|
|
2020
Q1 | $1.19M | Buy |
35,496
+6,952
| +24% | +$233K | 0.02% | 865 |
|
|
2019
Q4 | $1.29M | Buy |
28,544
+205
| +0.7% | +$9.29K | 0.02% | 977 |
|
|
2019
Q3 | $1.08M | Buy |
+28,339
| New | +$1.08M | 0.02% | 1032 |
|